Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (9) , 2797-2800
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Nicotinic Acid Receptor AgonistsJournal of Medicinal Chemistry, 2008
- Nicotinic Acid-Induced Flushing Is Mediated by Activation of Epidermal Langerhans CellsMolecular Pharmacology, 2006
- Langerhans Cells Release Prostaglandin D2 in Response to Nicotinic AcidJournal of Investigative Dermatology, 2006
- The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic targetTrends in Pharmacological Sciences, 2006
- Antagonism of the prostaglandin D 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humansProceedings of the National Academy of Sciences, 2006
- Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary reviewJournal of Internal Medicine, 2005
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001
- Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart DiseaseCirculation, 2001
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJACC, 1986
- HypertensionCirculation, 1973